Developer docs
API playgroundTry for free, no card

Search company profiles

NHC

Full company profile

uuid000met2

Namestring
NHC
Legal namestring
NHC SAS
Websiteurl
nhc.care
Company typeenum
Private
Founded yearint
2000
Descriptiontext

NHC (NHC Care SAS) is a French home healthcare provider (Prestataire de Santé à Domicile, PSAD) headquartered in Émerainville, France, founded in 2000. The company delivers four core clinical service lines at patients' homes across metropolitan France: insulin pump therapy for Type 1 and Type 2 diabetes, apomorphine pump therapy for Parkinson's disease, enteral and parenteral artificial nutrition, and home-based intravenous perfusion (antibiotic, chemotherapy, hydration). Service delivery is built around multidisciplinary care teams — approximately 150 nurses, 90 dietitians, 20 delivery technicians, and 20 administrative staff — combined with medical device provision (insulin pumps, apomorphine pumps such as Pentaferte Crono Par, FDE So Connect, Ever Pharma D Mine, infusion equipment), continuous glucose monitoring integrations (Dexcom G6/G7, Abbott Free Style Libre, Insulet Omnipod), 24/7 on-call nursing support, telemedicine/telesurveillance, and the NHC Academy educational platform for healthcare professionals and patients.

The business model is a regulated, reimbursement-driven services operation. NHC generates revenue through recurring monthly service packages (approximately €174.50/month bundling supplies, consumables, delivery, and 24/7 support), per-use consumables (e.g., €24.54 per catheter/replacement every 2–3 days), one-time onboarding training (€403 forfait de formation technique initiale), and device rental (€3.50/day, ~€105/month for insulin pumps). All therapy costs are reimbursed at 100% by French Sécurité Sociale under the tiers payant (third-party payment) framework, making NHC effectively a B2B2C provider with payor concentration in the French public health system. Go-to-market is relationship-driven: hospital discharge coordination, prescriber referrals from endocrinologists, neurologists, and general practitioners, complemented by patient community engagement through podcasts, NHC Academy workshops, and social channels (LinkedIn, Facebook, Instagram, TikTok).

The company holds Qualipsad quality certification (medical device vigilance for PSADs), is RGPD-compliant with an appointed DPO, and claims over 90,000 patients served daily and 20+ years of expertise. Leadership disclosed in source material is limited to Pierre Bourcier as Director of Publication; no broader management team, institutional investors, funding history, M&A activity, or revenue figures are publicly available. NHC operates exclusively in France and is privately held as a SAS with no identified parent company.

Short descriptiontext

NHC is a French home healthcare provider (PSAD) delivering insulin pump therapy, apomorphine pumps for Parkinson's, artificial nutrition, and home perfusion to over 90,000 patients daily across France, reimbursed by Sécurité Sociale through recurring monthly service packages.

Operating statusenum
Operating
Ownership categoryenum
Headcount rangeband
251–500
akta.pro rankint
HeadquartersÉmerainville, France
HQ citystring
Émerainville
HQ countrystring
France
HQ regionstring
Europe
Markets served

Serves global market

Offices1 record

Each record includes

City, Country, Type, Description, Source

Keyword5 values
home healthcare services, insulin pump therapy, artificial nutrition, apomorphine pump therapy, home infusion services
Industry2 codes
1Home-Based Chronic Disease Management (Skilled)
CodeHLADAFALPrimaryYes
2Injectables & Specialty Medication Support (e.g., insulin, biologics)
CodeHSABALAGPrimaryNo
NAICS code2 codes
  • Home Health Care Services62161
  • Home Health Care Services6216
SIC code2 codes
  • Services-Home Health Care Services8082
  • Services-Health Services8000
Product category
Home Healthcare Services
GTM motion2 records

Each record includes

Type, Description, Source

Revenue model2 records
1Medical Device Rental and Services
TypeSubscription Recurring
Description

NHC provides home healthcare services including medical device rental (insulin pumps, apomorphine pumps), consumables supply, and care coordination services. Revenue is generated through monthly service packages and per-use consumables, reimbursed by French social security (Sécurité Sociale) at 100% for eligible patients.

nhc.care
2Consumables and Accessories
TypeUsage Based
Description

Sale of disposable medical supplies including catheters, reservoirs, nutritional solutions, and tubing for enteral/parenteral nutrition and infusion therapies.

nhc.care
Marketing channels5 records

Each record includes

Title, Type, Stage, Description, Source

Distribution channels3 records

Each record includes

Title, Type, Scope, Target buyer, Description, Source

Cost components6 values
Personnel, Operations, Supply Chain, Infrastructure, Technology or R&D, Marketing or Sales
Pricing details4 tiers
1Insulin Pump Rental
ModelSubscriptionBilling cadenceMonthly
Notes

Monthly rental: €3.50/day (€105/month). Pump cost historically ~€2,600 to purchase (no longer available for purchase as of JO 30/04/09).

nhc.care
2Consumables Package
ModelUsage-basedBilling cadenceMonthly
Notes

Catheters, reservoirs and accessories: €24.54 per replacement (every 2-3 days).

nhc.care
3Initial Training Package
ModelOne time/ perpetual licenseBilling cadencePay-as-you-go
Notes

Forfait de formation technique initiale: €403 (one-time onboarding and training fee).

nhc.care
4Monthly Service Package
ModelSubscriptionBilling cadenceMonthly
Notes

Monthly package: €174.50 includes supplies, consumables, delivery, 24/7 on-call support, and equipment maintenance.

nhc.care
GTM typeB2C
B2C
Offering typeServices
Services
Brand1 of 2 records shown
1NHC Academy
Description

Educational platform offering free health training programs for healthcare professionals and diabetic patients, including workshops and webinars on diabetes management and insulin therapy.

nhc.care
+1 more record
Core offering1 text field

NHC provides home-based chronic disease management services as a French Prestataire de Santé à Domicile (PSAD). The company rents and services medical devices (insulin pumps, apomorphine pumps, infusion equipment), supplies consumables, and delivers care coordination through dedicated nurses and dietitians for four therapy areas: insulin pump therapy for diabetes, apomorphine pump therapy for Parkinson's disease, artificial nutrition (enteral and parenteral), and home infusion (perfusion). Services include device installation, patient and caregiver training, ongoing monitoring, consumables replenishment, 24/7 on-call support, and a secure web portal for prescriber reporting, all reimbursed by French social security.

Differentiator
Functional benefit
Problem solved
Quantifiable outcome1 of 4 values shown
  • 98% patient satisfaction rate with insulin pump therapy
+3 more records
Product overview1 text field

NHC (NHC CARE SAS) is a French home healthcare provider (Prestataire de Santé à Domicile - PSAD) offering a comprehensive portfolio of medical care services at patients' homes. The core offering includes four medical specializations: insulin pump therapy for diabetes, apomorphine pump therapy for Parkinson's disease, artificial nutrition (enteral and parenteral), and home infusion/perfusion. Supporting services include 24/7 on-call nursing support, telemedicine/telesurveillance, and the NHC Academy educational platform. The company serves over 90,000 patients nationally with a team of approximately 150 nurses, 90 dietitians, and 20 technicians. NHC provides medical devices including insulin pumps, apomorphine pumps (Crono Par, So Connect, D Mine), infusion equipment, and partners with continuous glucose monitoring systems (Dexcom, Free Style Libre).

Product and service7 records
1Insulin Pump Therapy (Insulinothérapie par Pompe)
CategoryHome Diabetes Care
Description

Home healthcare service providing insulin pump therapy for diabetes management, including pump device provision, patient training, 24/7 on-call support, and ongoing follow-up care by dedicated nurses.

2Apomorphine Pump Therapy (Traitement par Pompe à Apomorphine)
CategoryHome Parkinson's Care
Description

Continuous subcutaneous apomorphine infusion therapy for Parkinson's disease patients, including pump devices, accessories, and specialized nursing support delivered at home.

3Enteral Nutrition (Nutrition Entérale)
CategoryArtificial Nutrition
Description

Artificial nutrition delivered directly into the digestive system via nasogastric tube or gastrostomy button for patients unable to take food orally, supported by specialized dietitians.

4Parenteral Nutrition (Nutrition Parentérale)
CategoryArtificial Nutrition
Description

Intravenous nutrition therapy delivering macronutrients, electrolytes, vitamins, and trace elements directly into the bloodstream for patients who cannot be fed orally or enterally, including catheter care education.

5Home Perfusion (Perfusion à Domicile)
CategoryHome Infusion Services
Description

Home infusion therapy including antibiotic, chemotherapy, hydration, and other IV treatments administered via gravity, diffuser, or programmable pump at the patient's home.

6Telemedicine / Telesurveillance (Télésurveillance)
CategoryRemote Patient Monitoring
Description

Remote medical monitoring service enabling healthcare professionals to interpret patient data at a distance and adjust treatment plans.

7NHC Academy (Diabetes and IF Academy Training Platform)
CategoryHealthcare Professional Education
Description

Educational platform offering free functional insulin therapy training for healthcare professionals and informational workshops for diabetic patients via e-learning and live video conferences, including the IF Academy Adulte and Pédiatrie programs.

Scale indicator2 records

Each record includes

Type, Value, Description, Source

Partnership8 partners
Strategic tierCoreTypeStrategic or Co-development Partner
Description

Collaboration with Hôpitaux Universitaires de Strasbourg to develop educational films on good practices in parenteral nutrition to prevent catheter-related infections. Joint production of training content for healthcare professionals.

Strategic tierCoreTypeStrategic or Co-development Partner
Description

Partnership with Baxter (healthcare company specializing in hospital and home products) for educational content on parenteral nutrition best practices and catheter care.

Strategic tierCoreTypeStrategic or Co-development Partner
Description

Collaboration with Théradial for educational content on parenteral nutrition, specifically on the proper use of TauroLock locking solutions for catheter maintenance.

Strategic tierCoreTypeTechnology or Integration
Description

Integration and support for Dexcom G6 and G7 continuous glucose monitoring systems as part of diabetes management services. NHC handles device malfunction reporting and customer support.

Strategic tierCoreTypeTechnology or Integration
Description

Integration and support for Abbott's Free Style Libre 2+, Free Style Libre 3 glucose monitoring systems. NHC provides device support and malfunction handling for patients using these devices.

Strategic tierCoreTypeTechnology or Integration
Description

Partnership for Omnipod tubeless insulin pump system distribution and support in France. NHC provides patient training, device support, and malfunction reporting services.

Strategic tierCoreTypeTechnology or Integration
Description

Distribution and support of Pentaferte Crono Par and Crono Par 4 apomorphine pumps for Parkinson's disease treatment.

8SFNEP (Société Francophone de Nutrition Clinique et Métabolique)
Strategic tierMinorTypeStrategic or Co-development Partner
Description

Partnership with SFNEP providing clinical nutrition resources and information through their dedicated clinical nutrition website (nutritionclinique.fr).

nhc.care
Recent move5 records

Each record includes

Date, Type, Title, Description, Source

Expansion highlight5 records

Each record includes

Type, Description

Peers10 records
TypeBroad incumbent
Description

Global nutrition therapeutics business supplying enteral and parenteral nutrition products (including through home distribution channels). Comparable in the artificial nutrition vertical where NHC provides service around nutrition products — adjacent incumbent rather than direct home-care competitor.

TypeDirect peer
Description

French home healthcare subsidiary of Air Liquide providing respiratory therapies, home perfusion, and chronic disease services at home. Directly comparable as a national PSAD with a multi-vertical home service portfolio including diabetes, sleep, and respiratory — overlapping significantly with NHC's chronic disease in-home model.

TypeDirect peer
Description

French home healthcare group operating in home perfusion, nutrition, and chronic disease services as a PSAD. Directly comparable in artificial nutrition and home infusion — two of NHC's four core verticals — and competes for the same hospital discharge referrals.

TypeBroad incumbent
Description

Largest French private hospital group with growing home care and post-acute services. Comparable as a broad healthcare incumbent that captures chronic disease patients at the hospital discharge step — the primary referral channel for NHC's home services.

TypeBroad incumbent
Description

Major European long-term care operator with French roots, operating nursing homes and home health services. Comparable as a broad incumbent in the French chronic and elder care market, with overlapping reimbursement exposure and chronic disease patient base.

TypeDirect peer
Description

French home healthcare services provider (now part of Air Liquide's healthcare division) focused on respiratory care, sleep apnea, insulin pump therapy, and home perfusion. Operates the same PSAD model as NHC with overlapping diabetes and chronic disease verticals.

TypeBroad incumbent
Description

Large European (France-anchored) long-term and chronic care provider with residential nursing homes and home care services. While primarily facility-based, its home-care arm competes for chronic disease patients in similar reimbursement frameworks and shares the multi-vertical chronic disease orientation.

TypeEmerging player
Description

French medtech developing automated insulin delivery (closed-loop / hybrid closed-loop) systems for Type 1 diabetes. Comparable in the diabetes therapy vertical where NHC supports insulin pumps; Diabeloop represents an emerging technology-driven threat/adjacent that could shift pump service economics toward manufacturers.

TypeBroad incumbent
Description

Global medical nutrition division of Danone providing enteral nutrition and disease-specific nutrition products. Comparable in the artificial nutrition vertical where NHC delivers home service around these products; broader incumbent focused on product manufacturing and distribution.

TypeDirect peer
Description

Listed French provider of home medical equipment, respiratory care, perfusion, and diabetes services with national coverage. Highly comparable business model: device rental, consumables, and home-based clinical support reimbursed by Sécurité Sociale — competing head-to-head with NHC in chronic disease home therapy.

Market position
Strengths5 records

Each record includes

Headline, Details, Source

Weaknesses5 records

Each record includes

Headline, Details, Source

Competitive moat5 records

Each record includes

Type, Details

Key risks6 records

Each record includes

Headline, Details, Source

Key highlights7 records

Each record includes

Headline, Details, Source

Customer concentration

Classification, Details

Named customers7 records

Each record includes

Name, Industry, Type, Use case, Source, UUID

Segment4 records

Each record includes

Title, Type, Primary, Description, Pain point addressed, Use case, Source

Ideal customer profile2 records

Each record includes

Profile, Firmographic size, Sales motion, Sales cycle length, Buying structure, Purchase trigger, Buyer persona, Geography, Industry vertical, Primary use case, Description, Pain points, Evidence proof points, Target buyer

Technology focused
No
API detail
Has APIbool
No

Docs URL, Description

AI maturity
App detail

Has app

Feature4 records

Each record includes

Title, Differentiator, Description, Source

Core technology
Revenue estimate
Valuation estimate
Number of profiles
Profiles1 record

Each record includes

Name, Designation, Designation category, Overview, Profile commentary, Source

No data
Compliance2 records

Each record includes

Name, Class, Description

Funding overview

Funding stage, Last funding date, Total funding USD

Funding rounds

Each record includes

Round, Amount USD, Date, Pre money valuation, Total investors, Investors, News

Investors

Each record includes

Name, Type, Date of entry, Rounds participated, Website

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Each record includes

Name, Acquisition type, Announced date, Completed date, Status, Website, News

Investment

Each record includes

Name, Round, Announced date, Lead investor, Website, News

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

NHC

Home Healthcare Servicesnhc.care

NHC is a French home healthcare provider (PSAD) delivering insulin pump therapy, apomorphine pumps for Parkinson's, artificial nutrition, and home perfusion to over 90,000 patients daily across France, reimbursed by Sécurité Sociale through recurring monthly service packages.

What NHC does

NHC (NHC Care SAS) is a French home healthcare provider (Prestataire de Santé à Domicile, PSAD) headquartered in Émerainville, France, founded in 2000. The company delivers four core clinical service lines at patients' homes across metropolitan France: insulin pump therapy for Type 1 and Type 2 diabetes, apomorphine pump therapy for Parkinson's disease, enteral and parenteral artificial nutrition, and home-based intravenous perfusion (antibiotic, chemotherapy, hydration). Service delivery is built around multidisciplinary care teams — approximately 150 nurses, 90 dietitians, 20 delivery technicians, and 20 administrative staff — combined with medical device provision (insulin pumps, apomorphine pumps such as Pentaferte Crono Par, FDE So Connect, Ever Pharma D Mine, infusion equipment), continuous glucose monitoring integrations (Dexcom G6/G7, Abbott Free Style Libre, Insulet Omnipod), 24/7 on-call nursing support, telemedicine/telesurveillance, and the NHC Academy educational platform for healthcare professionals and patients.

The business model is a regulated, reimbursement-driven services operation. NHC generates revenue through recurring monthly service packages (approximately €174.50/month bundling supplies, consumables, delivery, and 24/7 support), per-use consumables (e.g., €24.54 per catheter/replacement every 2–3 days), one-time onboarding training (€403 forfait de formation technique initiale), and device rental (€3.50/day, ~€105/month for insulin pumps). All therapy costs are reimbursed at 100% by French Sécurité Sociale under the tiers payant (third-party payment) framework, making NHC effectively a B2B2C provider with payor concentration in the French public health system. Go-to-market is relationship-driven: hospital discharge coordination, prescriber referrals from endocrinologists, neurologists, and general practitioners, complemented by patient community engagement through podcasts, NHC Academy workshops, and social channels (LinkedIn, Facebook, Instagram, TikTok).

The company holds Qualipsad quality certification (medical device vigilance for PSADs), is RGPD-compliant with an appointed DPO, and claims over 90,000 patients served daily and 20+ years of expertise. Leadership disclosed in source material is limited to Pierre Bourcier as Director of Publication; no broader management team, institutional investors, funding history, M&A activity, or revenue figures are publicly available. NHC operates exclusively in France and is privately held as a SAS with no identified parent company.

NHC firmographics

Firmographics
Name
NHC
Legal name
NHC SAS
Website
https://nhc.care
Company type
Private
Founded year
2000
Operating status
Operating
Headcount range
251–500 employees
Short description
NHC is a French home healthcare provider (PSAD) delivering insulin pump therapy, apomorphine pumps for Parkinson's, artificial nutrition, and home perfusion to over 90,000 patients daily across France, reimbursed by Sécurité Sociale through recurring monthly service packages.
Ownership category
akta.pro rank

NHC industry classification

Industry
Product category
Home Healthcare Services
NAICS
Home Health Care Services (62161), Home Health Care Services (6216)
SIC
Services-Home Health Care Services (8082), Services-Health Services (8000)
akta.pro primary industry
Home-Based Chronic Disease Management (Skilled) (HLADAFAL)
akta.pro secondary industry
Injectables & Specialty Medication Support (e.g., insulin, biologics) (HSABALAG)

Keywords

  • Home healthcare services
  • Insulin pump therapy
  • Artificial nutrition
  • Apomorphine pump therapy
  • Home infusion services

Where NHC is headquartered

Location

Headquarters

HQ city
Émerainville
HQ country
France
HQ region
Europe

Offices1 record

Markets served

NHC business model

Business model
GTM type
B2C
Offering type
Services
Cost components
Personnel, Operations, Supply Chain, Infrastructure, Technology or R&D, Marketing or Sales

Revenue model

  1. Medical Device Rental and Services: NHC provides home healthcare services including medical device rental (insulin pumps, apomorphine pumps), consumables supply, and care coordination services. Revenue is generated through monthly service packages and per-use consumables, reimbursed by French social security (Sécurité Sociale) at 100% for eligible patients.
  2. Consumables and Accessories: Sale of disposable medical supplies including catheters, reservoirs, nutritional solutions, and tubing for enteral/parenteral nutrition and infusion therapies.

Pricing tiers

ModelBillingPrice
SubscriptionMonthlyInsulin Pump Rental
Usage-basedMonthlyConsumables Package
One time/ perpetual licensePay-as-you-goInitial Training Package
SubscriptionMonthlyMonthly Service Package

Go-to-market motion2 records

Distribution channels3 records

Marketing channels5 records

NHC product offering

Product offering

Core offering

NHC provides home-based chronic disease management services as a French Prestataire de Santé à Domicile (PSAD). The company rents and services medical devices (insulin pumps, apomorphine pumps, infusion equipment), supplies consumables, and delivers care coordination through dedicated nurses and dietitians for four therapy areas: insulin pump therapy for diabetes, apomorphine pump therapy for Parkinson's disease, artificial nutrition (enteral and parenteral), and home infusion (perfusion). Services include device installation, patient and caregiver training, ongoing monitoring, consumables replenishment, 24/7 on-call support, and a secure web portal for prescriber reporting, all reimbursed by French social security.

Product overview

NHC (NHC CARE SAS) is a French home healthcare provider (Prestataire de Santé à Domicile - PSAD) offering a comprehensive portfolio of medical care services at patients' homes. The core offering includes four medical specializations: insulin pump therapy for diabetes, apomorphine pump therapy for Parkinson's disease, artificial nutrition (enteral and parenteral), and home infusion/perfusion. Supporting services include 24/7 on-call nursing support, telemedicine/telesurveillance, and the NHC Academy educational platform. The company serves over 90,000 patients nationally with a team of approximately 150 nurses, 90 dietitians, and 20 technicians. NHC provides medical devices including insulin pumps, apomorphine pumps (Crono Par, So Connect, D Mine), infusion equipment, and partners with continuous glucose monitoring systems (Dexcom, Free Style Libre).

Differentiator

Problem solved

Functional benefit

Brands

  • NHC Academy: Educational platform offering free health training programs for healthcare professionals and diabetic patients, including workshops and webinars on diabetes management and insulin therapy.
  • IF Academy

Products and services

  • Insulin Pump Therapy (Insulinothérapie par Pompe) Home healthcare service providing insulin pump therapy for diabetes management, including pump device provision, patient training, 24/7 on-call support, and ongoing follow-up care by dedicated nurses.
  • Apomorphine Pump Therapy (Traitement par Pompe à Apomorphine) Continuous subcutaneous apomorphine infusion therapy for Parkinson's disease patients, including pump devices, accessories, and specialized nursing support delivered at home.
  • Enteral Nutrition (Nutrition Entérale) Artificial nutrition delivered directly into the digestive system via nasogastric tube or gastrostomy button for patients unable to take food orally, supported by specialized dietitians.
  • Parenteral Nutrition (Nutrition Parentérale) Intravenous nutrition therapy delivering macronutrients, electrolytes, vitamins, and trace elements directly into the bloodstream for patients who cannot be fed orally or enterally, including catheter care education.
  • Home Perfusion (Perfusion à Domicile) Home infusion therapy including antibiotic, chemotherapy, hydration, and other IV treatments administered via gravity, diffuser, or programmable pump at the patient's home.
  • Telemedicine / Telesurveillance (Télésurveillance) Remote medical monitoring service enabling healthcare professionals to interpret patient data at a distance and adjust treatment plans.
  • NHC Academy (Diabetes and IF Academy Training Platform) Educational platform offering free functional insulin therapy training for healthcare professionals and informational workshops for diabetic patients via e-learning and live video conferences, including the IF Academy Adulte and Pédiatrie programs.

Quantifiable outcome

  • 98% patient satisfaction rate with insulin pump therapy
  • +3 more outcomes

Companies that use NHC

Customer profile

Named customers7 records

Segments4 records

Ideal customer profiles2 records

NHC technology and API

Technology

Technology focussed No

API detail

Has API
No
API docs
API detail

Core technology

AI maturity

App detail

Feature4 records

NHC partnerships and signals

Strategic signal

Partnerships

Eight partnerships are on record, tiered core and minor.

  • Hôpitaux Universitaires de StrasbourgcoreStrategic or Co-development PartnerCollaboration with Hôpitaux Universitaires de Strasbourg to develop educational films on good practices in parenteral nutrition to prevent catheter-related infections. Joint production of training content for healthcare professionals.
  • BaxtercoreStrategic or Co-development PartnerPartnership with Baxter (healthcare company specializing in hospital and home products) for educational content on parenteral nutrition best practices and catheter care.
  • ThéradialcoreStrategic or Co-development PartnerCollaboration with Théradial for educational content on parenteral nutrition, specifically on the proper use of TauroLock locking solutions for catheter maintenance.
  • DexcomcoreTechnology or IntegrationIntegration and support for Dexcom G6 and G7 continuous glucose monitoring systems as part of diabetes management services. NHC handles device malfunction reporting and customer support.
  • Abbott (Free Style Libre)coreTechnology or IntegrationIntegration and support for Abbott's Free Style Libre 2+, Free Style Libre 3 glucose monitoring systems. NHC provides device support and malfunction handling for patients using these devices.
  • Insulet (Omnipod)coreTechnology or IntegrationPartnership for Omnipod tubeless insulin pump system distribution and support in France. NHC provides patient training, device support, and malfunction reporting services.
  • Pentaferte (Crono Par)coreTechnology or IntegrationDistribution and support of Pentaferte Crono Par and Crono Par 4 apomorphine pumps for Parkinson's disease treatment.
  • SFNEP (Société Francophone de Nutrition Clinique et Métabolique)minorStrategic or Co-development PartnerPartnership with SFNEP providing clinical nutrition resources and information through their dedicated clinical nutrition website (nutritionclinique.fr).

Scale indicators2 records

Recent moves5 records

Expansion highlights5 records

NHC competitors and assessment

Company assessment

Broad incumbents

  • Nestlé Health Science: Global nutrition therapeutics business supplying enteral and parenteral nutrition products (including through home distribution channels). Comparable in the artificial nutrition vertical where NHC provides service around nutrition products — adjacent incumbent rather than direct home-care competitor.
  • Ramsay Santé: Largest French private hospital group with growing home care and post-acute services. Comparable as a broad healthcare incumbent that captures chronic disease patients at the hospital discharge step — the primary referral channel for NHC's home services.
  • Korian: Major European long-term care operator with French roots, operating nursing homes and home health services. Comparable as a broad incumbent in the French chronic and elder care market, with overlapping reimbursement exposure and chronic disease patient base.
  • Orpea: Large European (France-anchored) long-term and chronic care provider with residential nursing homes and home care services. While primarily facility-based, its home-care arm competes for chronic disease patients in similar reimbursement frameworks and shares the multi-vertical chronic disease orientation.
  • Danone Nutricia: Global medical nutrition division of Danone providing enteral nutrition and disease-specific nutrition products. Comparable in the artificial nutrition vertical where NHC delivers home service around these products; broader incumbent focused on product manufacturing and distribution.

Direct peers

  • VitalAire (Air Liquide Healthcare): French home healthcare subsidiary of Air Liquide providing respiratory therapies, home perfusion, and chronic disease services at home. Directly comparable as a national PSAD with a multi-vertical home service portfolio including diabetes, sleep, and respiratory — overlapping significantly with NHC's chronic disease in-home model.
  • Sphère (Santé Cie group): French home healthcare group operating in home perfusion, nutrition, and chronic disease services as a PSAD. Directly comparable in artificial nutrition and home infusion — two of NHC's four core verticals — and competes for the same hospital discharge referrals.
  • LVL Médical (Air Liquide group): French home healthcare services provider (now part of Air Liquide's healthcare division) focused on respiratory care, sleep apnea, insulin pump therapy, and home perfusion. Operates the same PSAD model as NHC with overlapping diabetes and chronic disease verticals.
  • Bastide Le Confort Médical: Listed French provider of home medical equipment, respiratory care, perfusion, and diabetes services with national coverage. Highly comparable business model: device rental, consumables, and home-based clinical support reimbursed by Sécurité Sociale — competing head-to-head with NHC in chronic disease home therapy.

Emerging players

  • Diabeloop: French medtech developing automated insulin delivery (closed-loop / hybrid closed-loop) systems for Type 1 diabetes. Comparable in the diabetes therapy vertical where NHC supports insulin pumps; Diabeloop represents an emerging technology-driven threat/adjacent that could shift pump service economics toward manufacturers.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat5 records

Key risks6 records

Key highlights7 records

Customer concentration

NHC social profiles

Digital presence

NHC compliance and trust

Trust signal

Compliance2 records

NHC financial estimates

Financial estimate

Revenue estimate

Valuation estimate

NHC leadership team

Management profile

Number of profiles

Profiles1 record

NHC funding detail

Funding detail

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

NHC M&A and investment

M&A and investment

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about NHC

What does NHC do?

NHC provides home-based chronic disease management services as a French Prestataire de Santé à Domicile (PSAD). The company rents and services medical devices (insulin pumps, apomorphine pumps, infusion equipment), supplies consumables, and delivers care coordination through dedicated nurses and dietitians for four therapy areas: insulin pump therapy for diabetes, apomorphine pump therapy for Parkinson's disease, artificial nutrition (enteral and parenteral), and home infusion (perfusion). Services include device installation, patient and caregiver training, ongoing monitoring, consumables replenishment, 24/7 on-call support, and a secure web portal for prescriber reporting, all reimbursed by French social security.

Is NHC a public or private company?

NHC is a private company. It is classified as founder individual operated bootstrapped and is currently operating.

When was NHC founded?

NHC was founded in 2000. It employs 251 to 500 people.

Where is NHC based?

NHC is headquartered in Émerainville, France, in the Europe region.

How does NHC make money?

Two revenue lines are on record. Medical Device Rental and Services are the primary driver. The others are consumables and Accessories.

Who are NHC's main competitors?

Broad incumbents on record are Nestlé Health Science, Ramsay Santé, Korian, Orpea and Danone Nutricia. Direct peers are VitalAire (Air Liquide Healthcare), Sphère (Santé Cie group), LVL Médical (Air Liquide group) and Bastide Le Confort Médical. Diabeloop is listed as an emerging player.

Does NHC have an API?

No public API is recorded for NHC.

What industry is NHC in?

NHC's product category is Home Healthcare Services. Its primary akta.pro industry code is HLADAFAL, Home-Based Chronic Disease Management (Skilled), with a secondary code of HSABALAG, Injectables & Specialty Medication Support (e.g., insulin, biologics). Its NAICS code is 62161 and its SIC code is 8082.

Unlock the full company data

50 free credits on sign-up, no credit card required.

Contact sales
Live signals
Seeking AlphaNHI targets $500M-$700M annual acquisitions while holding 4.1x net debt to adjusted EBITDA and raising dividend to $0.94 (NYSE:NHI)National Health Investors (NHI) reported Q2 2026 earnings results, targeting $500M-$700M in annual acquisitions while maintaining a 4.1x net debt to adjusted EBITDA leverage ratio. The company raised its dividend to $0.94 and completed the NHC transaction, which management described as one of the most significant corporate actions in NHI's history that substantially strengthened the balance sheet by reducing leverage.AInvestNHC's 67-Cent Dividend Isn't the Alpha-21% Earnings Growth IsNHC announced a $0.67 quarterly dividend, representing a 4.7% increase over the prior quarter, for shareholders of record on June 30, 2026, payable July 31, 2026, which annualized equals $2.68 per share. The company also reported Q1 earnings with revenue up 2.2% to $381.8 million and adjusted diluted EPS of $1.91, a 21.1% increase in adjusted net income compared to the prior year. The article notes that while the dividend increase signals management confidence in operational stability, the earnings improvement is considered the more significant development for valuation if the trend continues.WikipediaTalk:2026 Pacific hurricane season: Difference between revisionsThe article discusses the standards and protocols for officially reporting Pacific hurricane season data, emphasizing the importance of relying on NOAA and NHC advisories over raw feeds or unofficial sources. It includes community discussions about data sourcing, technical issues, and classification of weather systems for the 2026 season.SciencedirectNHC-catalyzed covalent activation and control of P(V)-stereogenic phosphorus centers via phosphonyl azolium intermediatesThe article discusses an NHC-catalyzed covalent activation method for constructing P(V)-stereogenic phosphorus centers through phosphonyl azolium intermediates. It highlights the development of a two-stage synthesis platform enabling broad P–O/N bond formations and potential applications in agrochemicals and bioactive molecules. The approach offers a new strategy for the stereoselective synthesis of phosphorus compounds.SERVPRONHC 2023 Hurricane Season name pronunciation and storm outlook updatesThe National Hurricane Center released updated pronunciation guides for Atlantic Basin storm names covering the 2023-2028 hurricane seasons, with the Atlantic season beginning June 1. For the first time, the NHC is extending its potential storm formation outlooks from two to seven days, marking a significant operational expansion in forecast coverage. The article lists all assigned hurricane names for the 2023 Atlantic, Eastern Pacific, and Central North Pacific seasons.